RNU7-87P

Across TCGA pan-cancer cohorts, RNU7-87P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU7-87P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU7-87P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-87P expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

BLCA, LUSC, and UCS are the cancer types where RNU7-87P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.149	0.687	.005	99	view →
LUSC	OS	Tertile	II,III,IV	0.172	0.743	.003	36	view →
UCS	DFS	Tertile	All	0.126	0.523	.009	18	view →
OV	OS	Tertile	III,IV	1.000	0.311	.045	18	view →
SARC	OS	Tertile	All	0.164	0.734	<.001	18	view →
UCEC	DFS	Tertile	II,III,IV	0.099	0.511	.044	18	view →
PCPG	OS	Tertile	All	0.916	1.000	.010	9	view →
LGG	OS	Tertile	All	0.774	0.897	.030	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU7-87P–BLCA (OS)

Open the BLCA breakdown →